Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Neurology

Treatment Strategy: Medications & Lifestyle

At a Glance

Photosensitive Occipital Lobe Epilepsy (POLE) is managed by combining environmental modifications, such as wearing Zeiss Z1 blue-tinted lenses, with anti-seizure medications. Doctors often prescribe Levetiracetam or Lamotrigine as first-line treatments to block abnormal brain responses to light.

Managing Photosensitive Occipital Lobe Epilepsy (POLE) is a balancing act between reducing exposure to light triggers and using the right medical treatments to protect the brain. Because this is a reflex epilepsy, the goal is to stop the visual system from overreacting to the environment [1][2].

Lifestyle and Non-Drug Interventions

The first line of defense is often adjusting the visual environment to prevent the “reflex” from happening in the first place [3].

Specialized Blue Lenses

One of the most effective non-drug tools is the use of specialized blue-tinted lenses, such as the Zeiss Z1 [4].

  • How they work: These lenses are specifically designed to filter out the light frequencies that most often trigger a photoparoxysmal response (PPR) in the brain [4][5].
  • Efficacy: Research shows that these lenses can significantly reduce or even completely stop abnormal brain activity in over 50% of photosensitive patients [4].
  • Usage: They are often worn as “screen glasses” for television and video games, or as sunglasses for outdoor activities [5].

Environmental Control and Tech Settings

Small changes at home can significantly reduce seizure risk:

  • Lighting: Maintain a well-lit room when watching television or using a computer to reduce the contrast between the bright screen and the dark room [3].
  • Screen Hardware: Use high-refresh-rate monitors (100Hz or higher) which flicker less than older screens [1].
  • Accessibility Settings: Modern video games, TVs, and operating systems often have “reduce flashing lights” or “photosensitivity mode” toggles. Enabling these can strip out dangerous visual effects from media.

Medication Options (ASMs)

When environmental changes and specialized lenses aren’t enough, doctors prescribe Anti-Seizure Medications (ASMs).

Levetiracetam (Keppra)

Levetiracetam is frequently used as a first-line therapy because it is highly effective against both focal (occipital) and generalized seizures [6][7].

  • Benefits: It is generally considered highly effective and doesn’t require routine blood monitoring [8][9].
  • Side Effects: The most common concern is neuropsychiatric side effects, which can include increased irritability, aggression, or mood changes (sometimes called “Keppra-rage”) [10][11].

Lamotrigine (Lamictal)

Lamotrigine is a broad-spectrum anti-seizure medication that is often a preferred choice, particularly for adolescent females and young adults.

  • Benefits: It is highly effective for many types of seizures and typically has a much better mood profile than Keppra. It also avoids the severe reproductive risks associated with Valproate.
  • Side Effects: It must be increased very slowly to avoid a severe rash. It is generally very well tolerated once a maintenance dose is reached.

Valproate (Depakote)

Valproate is one of the most effective medications for treating photosensitivity, but it comes with a much higher risk profile [12].

  • Effectiveness: It is often used when other medications fail to stop the photoparoxysmal response on an EEG [13].
  • Significant Risks:
    • Reproductive Harm: For female patients, valproate is heavily avoided whenever possible due to high risks of severe birth defects and developmental issues if a pregnancy were to occur [14][15].
    • Cognitive Effects: Long-term use has been associated with risks to memory and intellectual development [14][16].
    • Structural Changes (Cortical Thinning): Research has noted that long-term valproate use may lead to a slight thinning of the gray matter in the visual cortex [17]. Note: This does not mean the brain is failing or that vision will be permanently lost; it is a microscopic change often seen on research scans, but doctors weigh this against the benefits of stopping seizures.

Because of these risks, valproate is usually reserved for cases where the seizures are frequent, severe, and resistant to other treatments [18][13].

Common questions in this guide

How do blue-tinted lenses help with photosensitive epilepsy?
Specialized blue-tinted lenses, like the Zeiss Z1, filter out specific light frequencies that trigger abnormal brain activity. Wearing these lenses can significantly reduce or completely stop the reflex response to light in over half of patients.
What lifestyle changes can help prevent photosensitive seizures?
Simple environmental adjustments can significantly reduce your risk, such as using high-refresh-rate monitors and maintaining a well-lit room while watching screens. You should also enable 'reduce flashing lights' or 'photosensitivity mode' in your device settings.
What are the common side effects of Levetiracetam (Keppra)?
While highly effective for controlling seizures, Levetiracetam can cause neuropsychiatric side effects. Patients and caregivers should monitor for unexpected mood changes, increased irritability, or aggression, often referred to as 'Keppra-rage'.
Is Valproate (Depakote) safe for young women with epilepsy?
Valproate is generally avoided for female patients because it carries a high risk of severe birth defects and developmental issues. It is usually reserved only for severe cases that do not respond to other anti-seizure medications.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.If we choose Levetiracetam, how should we monitor for behavioral changes like irritability or aggression?
  2. 2.Given the risks for females, is Lamotrigine a better first-line option for me/my daughter?
  3. 3.Are Zeiss Z1 lenses available in my prescription, and how do we acquire them?
  4. 4.What specific screening (blood tests or scans) should we do if starting on Valproate?
  5. 5.How often should we repeat the EEG to see if the lenses or medication are successfully blocking the photoparoxysmal response?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Photo-Dependent Reflex Seizures-A Scoping Review with Proposal of Classification.

    Strzelecka J, Mazurkiewicz DW, Skadorwa T, et al.

    Journal of clinical medicine 2022; (11(13)) doi:10.3390/jcm11133766.

    PMID: 35807051
  2. 2

    Visually sensitive seizures: An updated review by the Epilepsy Foundation.

    Fisher RS, Acharya JN, Baumer FM, et al.

    Epilepsia 2022; (63(4)):739-768 doi:10.1111/epi.17175.

    PMID: 35132632
  3. 3

    Photosensitive Epilepsy and Polycystic Ovary Syndrome as Manifestations of MERRF.

    Finsterer J

    Case reports in neurological medicine 2020; (2020()):8876272 doi:10.1155/2020/8876272.

    PMID: 33062354
  4. 4

    [Efficiency of the photostimulation in activation of the EEG paroxysmal disorders in children depending on frequency spectrum of the luminous stimulus--preliminary report].

    Strzelecka J, Skadorwa T, Kuszczak-Bohl B

    Przeglad lekarski 2015; (72(11)):620-1.

    PMID: 27012119
  5. 5

    Efficacy of color lenses in abolishing photosensitivity: Beyond the one-type-fits-all approach?

    Checa-Ros A, Kasteleijn-Nolst Trenite D, Edson-Scott A, et al.

    Epilepsy & behavior : E&B 2021; (124()):108332 doi:10.1016/j.yebeh.2021.108332.

    PMID: 34619544
  6. 6

    Efficacy and Safety of Levetiracetam for Childhood Epilepsies.

    Catibusic FH, Uzicanin S, Salihbegovic EV, Huseinbegovic Z

    Medical archives (Sarajevo, Bosnia and Herzegovina) 2024; (78(2)):122-126 doi:10.5455/medarh.2024.78.122-126.

    PMID: 38566869
  7. 7

    Antiepileptic drug prescription in Dutch children from 2006-2014 using pharmacy-dispensing data.

    Weijenberg A, Bos JHJ, Schuiling-Veninga CCM, et al.

    Epilepsy research 2018; (146()):21-27 doi:10.1016/j.eplepsyres.2018.07.011.

    PMID: 30056317
  8. 8

    Micronization potentiates curcumin's anti-seizure effect and brings an important advance in epilepsy treatment.

    Bertoncello KT, Aguiar GPS, Oliveira JV, Siebel AM

    Scientific reports 2018; (8(1)):2645 doi:10.1038/s41598-018-20897-x.

    PMID: 29422541
  9. 9

    Efficacy and safety of levetiracetam versus phenobarbitone for neonatal seizures: A systemic review and meta-analysis.

    Salim N, Qadri SI, Chughtai MAI, et al.

    Clinical neurology and neurosurgery 2025; (258()):109155 doi:10.1016/j.clineuro.2025.109155.

    PMID: 40975024
  10. 10

    The Effect of Levetiracetam and Valproic Acid Treatment on Anger and Attention Deficit Hyperactivity Disorder Clinical Features in Children and Adolescents with Epilepsy: A Prospective Study.

    Vatansever Pınar Z, Sağer SG, Çimen İD, Çağ Y

    Paediatric drugs 2024; (26(6)):753-765 doi:10.1007/s40272-024-00652-8.

    PMID: 39331340
  11. 11

    Can Pyridoxine Successfully Reduce Behavioral Side Effects from Levetiracetam?: A Critically Appraised Topic.

    Chhabra N, Vanood A, Hoerth MT, et al.

    The neurologist 2023; (28(5)):349-352 doi:10.1097/NRL.0000000000000496.

    PMID: 37083708
  12. 12

    Valproate encephalopathy: Case series and literature review.

    Pan C, Zhao Z, Liu Z, et al.

    SAGE open medical case reports 2024; (12()):2050313X241260152 doi:10.1177/2050313X241260152.

    PMID: 38911175
  13. 13

    Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy.

    Cohen JM, Alvestad S, Suarez EA, et al.

    Neurology 2024; (102(2)):e207996 doi:10.1212/WNL.0000000000207996.

    PMID: 38165339
  14. 14

    Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine Exposure.

    Hernández-Díaz S, Straub L, Bateman BT, et al.

    The New England journal of medicine 2024; (390(12)):1069-1079 doi:10.1056/NEJMoa2309359.

    PMID: 38507750
  15. 15

    Safety update: valproate safety and educational materials.

    Drug and therapeutics bulletin 2024; (62(4)):53 doi:10.1136/dtb.2024.000013.

    PMID: 38417949
  16. 16

    Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones.

    Daugaard CA, Pedersen L, Sun Y, et al.

    JAMA network open 2020; (3(11)):e2025570 doi:10.1001/jamanetworkopen.2020.25570.

    PMID: 33170264
  17. 17

    Valproate Use Is Associated With Posterior Cortical Thinning and Ventricular Enlargement in Epilepsy Patients.

    Tondelli M, Vaudano AE, Sisodiya SM, Meletti S

    Frontiers in neurology 2020; (11()):622 doi:10.3389/fneur.2020.00622.

    PMID: 32714274
  18. 18

    Efficacy of levetiracetam, lamotrigine and sodium valproate on seizure attacks and EEG disorders in patients with juvenile myoclonic epilepsy: A double blind randomized clinical trial.

    Daneshyar S, Ghiasian M, Moradi S, Khanlarzadeh E

    Caspian journal of internal medicine 2022; (13(3)):617-622 doi:10.22088/cjim.13.3.617.

    PMID: 35974938

This page provides educational information on treatment strategies for Photosensitive Occipital Lobe Epilepsy. Always consult your neurologist or epileptologist before changing medications or making significant lifestyle interventions.

Get notified when new evidence is published on Photosensitive occipital lobe epilepsy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.